| Primary |
| Orthostatic Hypotension |
11.9% |
| Addison's Disease |
9.5% |
| Hypotension |
9.5% |
| Multiple Sclerosis |
9.5% |
| Dementia Alzheimer's Type |
7.1% |
| Postural Orthostatic Tachycardia Syndrome |
7.1% |
| Adrenogenital Syndrome |
4.8% |
| Insomnia |
4.8% |
| Myoclonus |
4.8% |
| Orthostatic Hypertension |
4.8% |
| Pain |
4.8% |
| 21-Hydroxylase Deficiency |
2.4% |
| Adrenal Carcinoma |
2.4% |
| Adrenalectomy |
2.4% |
| Amyloidosis |
2.4% |
| Autonomic Nervous System Imbalance |
2.4% |
| Blood Aldosterone Decreased |
2.4% |
| Breakthrough Pain |
2.4% |
| Constipation |
2.4% |
| Mineral Supplementation |
2.4% |
|
| Dizziness |
10.3% |
| Somnolence |
10.3% |
| Vomiting |
10.3% |
| Intestinal Obstruction |
6.9% |
| Orthostatic Hypotension |
6.9% |
| Visual Acuity Reduced |
6.9% |
| Adverse Event |
3.4% |
| Angioneurotic Oedema |
3.4% |
| Blood Pressure Decreased |
3.4% |
| Blood Pressure Systolic Increased |
3.4% |
| Blood Sodium Decreased |
3.4% |
| Breast Pain |
3.4% |
| Breast Tenderness |
3.4% |
| Confusional State |
3.4% |
| Disease Progression |
3.4% |
| Dysphagia |
3.4% |
| Dyspnoea |
3.4% |
| Dysuria |
3.4% |
| False Negative Laboratory Result |
3.4% |
| Hospitalisation |
3.4% |
|
| Secondary |
| Dementia Alzheimer's Type |
27.3% |
| Adrenogenital Syndrome |
11.7% |
| Hypotension |
11.7% |
| Product Used For Unknown Indication |
9.4% |
| Hypertension |
6.3% |
| Multiple Sclerosis |
4.7% |
| Addison's Disease |
3.9% |
| Pain |
3.1% |
| Postural Orthostatic Tachycardia Syndrome |
3.1% |
| Diarrhoea |
2.3% |
| Parkinson's Disease |
2.3% |
| Acth Decreased |
1.6% |
| Adrenal Insufficiency |
1.6% |
| Crohn's Disease |
1.6% |
| Deep Vein Thrombosis |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Dyspepsia |
1.6% |
| Epinephrine Decreased |
1.6% |
| Nausea |
1.6% |
| Nervous System Disorder |
1.6% |
|
| Somnolence |
21.1% |
| Vomiting |
13.2% |
| Tremor |
7.9% |
| Benign Hydatidiform Mole |
5.3% |
| Dysuria |
5.3% |
| Fat Necrosis |
5.3% |
| Hypernatraemia |
5.3% |
| Syncope |
5.3% |
| Bradycardia |
2.6% |
| Dizziness |
2.6% |
| Femur Fracture |
2.6% |
| Hepatitis |
2.6% |
| Hot Flush |
2.6% |
| Hypotension |
2.6% |
| International Normalised Ratio Increased |
2.6% |
| Liver Disorder |
2.6% |
| Medication Error |
2.6% |
| Multiple Sclerosis Relapse |
2.6% |
| Musculoskeletal Chest Pain |
2.6% |
| Orthostatic Hypotension |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Drug Use For Unknown Indication |
17.3% |
| Multiple Myeloma |
6.5% |
| Nuclear Magnetic Resonance Imaging |
4.2% |
| Hypertension |
4.1% |
| Addison's Disease |
3.9% |
| Hypotension |
3.5% |
| Pain |
3.3% |
| Depression |
3.1% |
| Osteoporosis |
3.1% |
| Prophylaxis |
3.1% |
| Asthma |
3.0% |
| Anxiety |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Metastases To Bone |
2.3% |
| Prostate Cancer |
2.2% |
| Parkinson's Disease |
2.2% |
| Renal Transplant |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Muscle Spasms |
2.0% |
|
| Weight Decreased |
18.7% |
| Vomiting |
16.7% |
| Weight Increased |
6.8% |
| Syncope |
5.4% |
| Pyrexia |
5.1% |
| Urinary Tract Infection |
5.1% |
| Hypotension |
4.8% |
| Pneumonia |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Drug Ineffective |
3.4% |
| Death |
3.1% |
| Renal Infarct |
3.1% |
| Hallucination |
2.7% |
| Skin Tightness |
2.7% |
| Vertigo |
2.7% |
| X-ray Abnormal |
2.7% |
| Fatigue |
2.4% |
| Orthostatic Hypotension |
2.4% |
| Pain |
2.4% |
| Pharmaceutical Product Complaint |
2.4% |
|
